← Leaderboards
Richard Kimo Baldwin
Nanocomposix, Inc.
$304,226
Attributed
$688,056
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $463.1K · FY2018–19$500K$375K$250K$125K$0
'18
'19
Funding mix
By agency
NIH$688,056 · 3
By mechanism
R41$463,056 · 2
R43$225,000 · 1
Top collaborators
- Marco Antonio Biamonte2 shared
- Peter Uwe Fischer1 shared
- Nora Pisanic1 shared
Most similar at Nanocomposix, Inc.
Same institution · by research overlap
- Marco Antonio Biamonte$5,727,635
- Nora Pisanic$112,500
- Peter Uwe Fischer$468,283
Others in their field
Other Emerging Leaders on “Diagnostic”
- Bambra Strokes · Ppd Development Lp$526,656,217
- Leonard Freedman · Leidos Biomedical Research, Inc.$293,634,608
- Lynn Briscoe · Leidos Biomedical Research, Inc.$100,239,656
- Leonard Freedmand · Leidos Biomedical Research, Inc.$63,918,621
- Mark Marino · Venturewell$61,502,138
- Scott Topper · Broad Institute, Inc.$51,811,587
Research focus
DiagnosticInfectionAntibodiesResponseAntigensImmunoglobulin GNanoshellSamplingDiagnostic TestsDetectionGoldBiological MarkersBaseImmunoassayIgg4Filaria BancroftiCenters For Disease Control And Prevention (U.S.)Filarial ElephantiasesAffectAreaExperimental StudyExposure ToDiagnosisClinical Sensitivity
Grant awards (3)
The first commercial rapid diagnostic test to detect Paragonimus infections$238,810
R41 · FY2019 · AI · contact PI
Ultra-sensitive Rapid Diagnostic Test to Support the End-Game of the Global Program to Eliminate Lymphatic Filariasis$224,246
R41 · FY2019 · AI · contact PI
Development of a point of care lateral flow diagnostic to test for acute and past hepatitis E (HEV) in saliva$225,000
R43 · FY2018 · AI · contact PI